VJHemOnc is committed to improving our service to you

ASCO 2019 | COLUMBA: subcutaneous daratumumab vs. IV administration

VJHemOnc is committed to improving our service to you

Maria-Victoria Mateos

Maria-Victoria Mateos, MD, PhD, of the Institute of Biomedical Research of Salamanca, Salamanca, Spain, discusses the COLUMBA (NCT03277105) study which investigated subcutaneous daratumumab administration in patients with relapsed or refractory multiple myeloma vs. an IV administration. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter